Probability of occurrence of undesirable effects of drug interactions in the treatment of suppurative meningitis
Klimova, E.A.; Timina, V.P.
Sovetskaia Meditsina 12: 119-121
1986
ISSN/ISBN: 0038-5077 PMID: 3563696 Document Number: 280855
Document emailed within 1 workday
Related Documents
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64Reinicke, C.; Wessel, G. 1979: Undesirable drug interactions. Notes on general principles Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(18): 504-505
Filipczyk-Cisarz, E. 2000: Clinical implications of undesirable consequences of antineoplastic drug interactions Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 9(51): 632-633
García Morillas, M.; Caracuel Ruiz, M.D.; Sánchez de la Cuesta, F. 1988: Interactions and undesirable side effects of platelet aggregation inhibitors Medicina Clinica 90(13): 553-555
Grille, W.; Johnsen, K.; Kolenda, K.D. 1979: Conditions for the occurrence of drug interactions during biotransformation Medizinische Klinik 74(3): 55-67
Lechat, P. 1974: Periodical re-evaluation of the undesirable side effects of old drugs. An important mission of drug surveillance La Nouvelle Presse Medicale 3(24): 1571-1573
Krasovitskiĭ, Z.I. 1970: Several problems in the treatment of suppurative meningitis Klinicheskaia Meditsina 48(9): 103-108
Mozziconacci, P.; Le Bouar, Y. 1971: Treatment of suppurative meningitis due to multiresistant bacteria Annales de Medecine Interne 122(10): 1031-1036
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Franczak, T.; Modrzewska, B. 1981: Clinical course and treatment of suppurative cerebrospinal meningitis in children Wiadomosci Lekarskie 34(4): 285-290
Kovrizhnykh, N.A.; Kazantsev, A.G. 1992: A case of successful treatment of a severe form of suppurative meningitis Anesteziologiia i Reanimatologiia 2: 70-71
Rodrigues-Barata, A.R.; Camacho-Martínez, F.M. 2013: Undesirable effects after treatment with dermal fillers Journal of Drugs in Dermatology: Jdd 12(4): E59-E62
Godula-Stuglik, U.; Gajewska, J.; Woźniak, F. 1984: Causes of unfavorable results in the treatment of suppurative cerebrospinal meningitis in newborn infants Pediatria Polska 59(4): 295-302
Stahl, J.P. 1998: Suppurative meningitis. Epidemiology, etiology, diagnosis, evolution, treatment, prevention La Revue du Praticien 48(15): 1681-1688
Pokrovskaia, N.I.; Petrunin, I.P.; Trefilova, I.S.; Raĭner, M.A.; Bogatyreva, E.P. 1983: Characteristics of clinical course and treatment of children with suppurative Haemophilus influenzae meningitis Pediatriia 7: 33-34
Thilmann, A.F.; Mobius, E.; Thilmann, R.R.; Topper, R. 1991: Rezidivierende aseptische Meningitis (Mollaret-Meningitis)―spontanes und medikamentös induziertes Auftreten - Recurrent aseptic meningitis (Mollaret-Meningitis)―spontaneous and drug-induced appearance Fortschritte der Neurologie, Psychiatrie 59(12): 493-497
Henrichsen, L.; Pedersen, H.; Jensen, K.B.; Wulff, H.R. 1976: Undesirable effects of carbenoxolone treatment in patients with ulcus ventriculi Ugeskrift for Laeger 138(51): 3265-3267
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Garrone, G.; Balant, L.; Balant-Gorgia, A. 1987: Problems encountered in the pharmacological treatment of depression (resistance to treatment, metabolic problems, undesirable secondary effects, non-compliance) Revue Medicale de la Suisse Romande 107(12): 1007-1012
Schelling, J.L. 1976: Drug interactions and side effects Schweizerische Medizinische Wochenschrift 106(27): 905-908